A novel SGLT2 inhibitor, SU ‐011, improves glycaemic control in rodents without the risk of hypoglycaemia and weight gain
ConclusionsAll of these results indicated that SU ‐011 may be effective for the management of diabetes.
Source: Journal of Pharmacy and Pharmacology - Category: Drugs & Pharmacology Authors: Fei Huang,
Fuwei Dai,
Jianhua Bi,
Lanxiang Hao,
Chunlei Wang,
Ke Xu,
Yanmei Liu,
Xingbo Cheng Tags: Research Paper Source Type: research
More News: Dapagliflozin | Diabetes | Drugs & Pharmacology | Endocrinology | Forxiga | Insulin | SGLT2 Inhibitors | Study